title: SSRIs and placental dysfunction.
authors.forename: Alok
authors.initials: A
authors.lastname: Banga
authors.forename: Venkatesh
authors.initials: V
authors.lastname: Handratta
authors.forename: Lobna
authors.initials: L
authors.lastname: Ibrahim
authors.forename: Daniel F
authors.initials: DF
authors.lastname: Connor
mesh_terms: D003865:Major Depressive Disorder / Q000150:complications* / Q000188:drug therapy*; D005231:Fatty Acids, Unsaturated / Q000378:metabolism; D005260:Female; D006801:Humans; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000378:metabolism*; D015227:Lipid Peroxidation / Q000502:physiology; D018384:Oxidative Stress / Q000502:physiology*; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy; D026361:Reactive Nitrogen Species / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000494:pharmacology*; D014364:Tryptophan / Q000378:metabolism
chemical_list: D005231:Fatty Acids, Unsaturated; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D026361:Reactive Nitrogen Species; D017382:Reactive Oxygen Species; D017367:Selective Serotonin Reuptake Inhibitors; D014364:Tryptophan